3rd How I Manage CAR-T Therapies and Bispecific Antibodies for my Patients

Conference Details

Date: 26 September 2025

Time: 08:15

Duration: 3 days

Location: Stockholm, Sweden

Cost: € 300 - € 600

Organiser: ESH - European School of Haematology

Conference Website

Conference Description

Chairs: Caron Jacobson, Ulrich Jäger, Marie José Kersten

ABOUT THE CONFERENCE:

The format of the meeting is based on the analysis and discussion of clinical case studies. It will adopt a problem-solving approach, addressing practical considerations and guidelines. Emphasis will be placed on open discussion, ensuring a maximum level of interaction between faculty and registered participants.

MAIN SCIENTIFIC TOPICS:

• Non-hodgkin lymphoma;
• Multiple myeloma;
• Novel indications of CAR T-cell therapy;
• 1^st line high-risk large B-cell lymphoma: which randomized controlled trial would you prioritize for your patient?
• Access to CAR-T and bispecific across the globe;
• Predictors of response and toxicity of CAR and bispecific;
• Access issues in CAR T-cell treatment;
• CAR-T vs bispecific antibody in multiple myeloma;
• Real world data for CAR-T and bispecific;
• Next Generation of CAR T-cell and bispecific antibody therapy.

LEARNING OBJECTIVES:

• Understanding of the current landscape of bispecific antibodies in NHL and MM;
• Understanding of the current landscape of CAR-T cell therapy in NHL and MM;
• Novel approaches and technologies in the field;
• Integration of novel therapies into current clinical practice;
• Understanding the management of side effects of CAR T-cell therapy and bispecific antibodies;
• Understand potential indications and sequencing of CAR-T cells and bispecifics.

THE PROGRAMME WILL INCLUDE:

• Keynote lectures;
• Case-based lectures;
• Interactive Case Presentations;
• Roundtables;
• Panel Discussions;
• Debates;
• Poster Walks;
• Meet the Expert Sessions;
• Voting technology.